Describing the advantages and limitations of the key technologies used in (onco)proteogenomics

Explaining how oncoproteomics can assist us in understanding the biology behind the overarching “Hallmarks of Cancer”

Discussing the future directions in the field and how they can advance the development of precision/personalised medicine